State Street SPDR S&P Pharmaceuticals ETF (XPH)
NYSEARCA: XPH · Real-Time Price · USD
57.02
+0.54 (0.96%)
At close: Jan 21, 2026, 4:00 PM EST
57.02
0.00 (0.00%)
After-hours: Jan 21, 2026, 6:30 PM EST
XPH Holdings Information
XPH is an equity ETF with a total of 60 individual holdings. The top holdings are MBX Biosciences stock at 2.77%, Definium Therapeutics at 2.51%, Organon & Co. at 2.44%, Amylyx Pharmaceuticals at 2.31%, and Axsome Therapeutics at 2.29%.
Total Holdings
60
Top 10 Percentage
23.09%
Asset Class
Equity
ETF Category
Health
Assets
232.25M
PE Ratio
16.73
Sector Allocation
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | MBX | MBX Biosciences, Inc. | 2.77% |
| 2 | DFTX | Definium Therapeutics, Inc. | 2.51% |
| 3 | OGN | Organon & Co. | 2.44% |
| 4 | AMLX | Amylyx Pharmaceuticals, Inc. | 2.31% |
| 5 | AXSM | Axsome Therapeutics, Inc. | 2.29% |
| 6 | EWTX | Edgewise Therapeutics, Inc. | 2.24% |
| 7 | LQDA | Liquidia Corporation | 2.23% |
| 8 | CRNX | Crinetics Pharmaceuticals, Inc. | 2.14% |
| 9 | ELAN | Elanco Animal Health Incorporated | 2.10% |
| 10 | MRK | Merck & Co., Inc. | 2.07% |
| 11 | PRGO | Perrigo Company plc | 2.06% |
| 12 | XERS | Xeris Biopharma Holdings, Inc. | 2.03% |
| 13 | AMRX | Amneal Pharmaceuticals, Inc. | 2.02% |
| 14 | VTRS | Viatris Inc. | 2.02% |
| 15 | SUPN | Supernus Pharmaceuticals, Inc. | 2.00% |
| 16 | LGND | Ligand Pharmaceuticals Incorporated | 1.97% |
| 17 | BMY | Bristol-Myers Squibb Company | 1.96% |
| 18 | JNJ | Johnson & Johnson | 1.95% |
| 19 | PBH | Prestige Consumer Healthcare Inc. | 1.95% |
| 20 | LLY | Eli Lilly and Company | 1.94% |
| 21 | ANIP | ANI Pharmaceuticals, Inc. | 1.93% |
| 22 | ZTS | Zoetis Inc. | 1.93% |
| 23 | RPRX | Royalty Pharma plc | 1.89% |
| 24 | ELVN | Enliven Therapeutics, Inc. | 1.89% |
| 25 | JAZZ | Jazz Pharmaceuticals plc | 1.88% |
As of Jan 16, 2026